1
|
Leone GM, Candido S, Lavoro A, Vivarelli S, Gattuso G, Calina D, Libra M, Falzone L. Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics 2023; 15:1252. [PMID: 37111737 PMCID: PMC10142433 DOI: 10.3390/pharmaceutics15041252] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 04/12/2023] [Accepted: 04/14/2023] [Indexed: 04/29/2023] Open
Abstract
Lung cancer (LC) represents the second most diagnosed tumor and the malignancy with the highest mortality rate. In recent years, tremendous progress has been made in the treatment of this tumor thanks to the discovery, testing, and clinical approval of novel therapeutic approaches. Firstly, targeted therapies aimed at inhibiting specific mutated tyrosine kinases or downstream factors were approved in clinical practice. Secondly, immunotherapy inducing the reactivation of the immune system to efficiently eliminate LC cells has been approved. This review describes in depth both current and ongoing clinical studies, which allowed the approval of targeted therapies and immune-checkpoint inhibitors as standard of care for LC. Moreover, the present advantages and pitfalls of new therapeutic approaches will be discussed. Finally, the acquired importance of human microbiota as a novel source of LC biomarkers, as well as therapeutic targets to improve the efficacy of available therapies, was analyzed. Therapy against LC is increasingly becoming holistic, taking into consideration not only the genetic landscape of the tumor, but also the immune background and other individual variables, such as patient-specific gut microbial composition. On these bases, in the future, the research milestones reached will allow clinicians to treat LC patients with tailored approaches.
Collapse
Affiliation(s)
- Gian Marco Leone
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
| | - Saverio Candido
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
- Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy
| | - Alessandro Lavoro
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
| | - Silvia Vivarelli
- Department of Biomedical and Dental Sciences, Morphological and Functional Imaging, Section of Occupational Medicine, University of Messina, 98125 Messina, Italy
| | - Giuseppe Gattuso
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
| | - Daniela Calina
- Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
| | - Massimo Libra
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
- Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy
| | - Luca Falzone
- Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, 80131 Naples, Italy;
| |
Collapse
|
2
|
Pérol O, Lepage N, Noelle H, Lebailly P, de Labrusse B, Clin B, Boulanger M, Praud D, Fournié F, Galvaing G, Dutheil F, Le Meur B, Serin D, Dansin E, Nisse C, Charbotel B, Fervers B. A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:5068. [PMID: 36981979 PMCID: PMC10049492 DOI: 10.3390/ijerph20065068] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Revised: 03/10/2023] [Accepted: 03/12/2023] [Indexed: 06/18/2023]
Abstract
Occupational lung cancer cases remain largely under-reported and under-compensated worldwide. In order to improve the detection and compensation of work-related lung cancers, we implemented a systematic screening of occupational exposures, combining a validated self-administered questionnaire to assess occupational exposures and a specialized occupational cancer consultation. After a pilot study, the present prospective, open-label, scale-up study aimed to assess this systematic screening of occupational exposures in lung cancer patients in five sites in France by associating university hospitals with cancer centers. Patients with lung cancer were sent a self-administered questionnaire to collect their job history and potential exposure to lung carcinogens. The questionnaire was assessed by a physician to determine if a specialized occupational cancer consultation was required. During the consultation, a physician assessed if the lung cancer was occupation-related and, if it was, delivered a medical certificate to claim for compensation. Patients were offered help from a social worker for the administrative procedure. Over 15 months, 1251 patients received the questionnaire and 462 returned it (37%). Among them, 176 patients (38.1%) were convened to the occupational cancer consultation and 150 patients attended the consultation. An exposure to occupational lung carcinogen was identified in 133 patients and a claim for compensation was judged possible for 90 patients. A medical certificate was delivered to 88 patients and 38 patients received compensation. Our national study demonstrated that a systematic screening of occupational exposures is feasible and will bring a significant contribution to improve the detection of occupational exposures in lung cancer patients.
Collapse
Affiliation(s)
- Olivia Pérol
- Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France
- INSERM U1296 Radiations: Défense, Santé, Environnement, Centre Léon Bérard, 69373 Lyon, France
| | - Nadège Lepage
- CHU Lille, Centre Régional de Pathologies Professionnelles et Environnementales, 59800 Lille, France
- CHU Lille, ULR 4483-IMPECS-IMPact de l’Environnement Chimique sur la Santé Humaine, University of Lille, 59000 Lille, France
| | - Hugo Noelle
- Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France
- Faculté de Médecine, Université Claude Bernard Lyon 1, 69373 Lyon, France
- Service d’Evaluation Economique en Santé, Hospices Civils de Lyon, Pôle de Santé Publique, 69003 Lyon, France
| | - Pierre Lebailly
- INSERM U1086, Unité de Recherche Interdisciplinaire pour la Prévention et le Traitement des Cancers, Université de Caen Normandie, UFR Santé, 14032 Caen, France
- Centre François Baclesse, 14076 Caen, France
| | | | - Bénédicte Clin
- INSERM U1086, Unité de Recherche Interdisciplinaire pour la Prévention et le Traitement des Cancers, Université de Caen Normandie, UFR Santé, 14032 Caen, France
- Service de Santé au Travail et Pathologie Professionnelle, CHRU de Caen, 14033 Caen, France
| | | | - Delphine Praud
- Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France
- INSERM U1296 Radiations: Défense, Santé, Environnement, Centre Léon Bérard, 69373 Lyon, France
| | - Françoise Fournié
- Département Interdisciplinaire des Soins de Support du Patient en Oncologie, Service Social, Centre Léon Bérard, 69373 Lyon, France
| | - Géraud Galvaing
- Chirurgie Thoracique, Centre Jean Perrin, 63011 Clermont-Ferrand, France
| | - Frédéric Dutheil
- Université Clermont Auvergne, CNRS, LaPSCo, Service Santé Travail Environnement, CHU Clermont Ferrand, 63011 Clermont-Ferrand, France
| | | | - Daniel Serin
- Institut du Cancer Sainte Catherine, 84918 Avignon, France
| | - Eric Dansin
- Département d’Oncologie Médicale, Centre Oscar Lambret, 59000 Lille, France
| | - Catherine Nisse
- CHU Lille, Centre Régional de Pathologies Professionnelles et Environnementales, 59800 Lille, France
- CHU Lille, ULR 4483-IMPECS-IMPact de l’Environnement Chimique sur la Santé Humaine, University of Lille, 59000 Lille, France
| | - Barbara Charbotel
- UMRESTTE (Unité Mixte IFSTTAR/UCBL), Université Lyon 1, 69373 Lyon, France
- Service des Maladies Professionnelles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France
| | - Beatrice Fervers
- Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France
- INSERM U1296 Radiations: Défense, Santé, Environnement, Centre Léon Bérard, 69373 Lyon, France
| |
Collapse
|
3
|
Noelle H, Pérol O, Pérol M, Avrillon V, Belladame E, Fayette J, Fournié F, Swalduz A, Dessemon J, Blay JY, Neidhardt EM, Saintigny P, Tabutin M, Boussageon M, Praud D, Charbotel B, Fervers B. Occupational asbestos exposure and survival among lung cancer patients. Lung Cancer 2023; 179:107182. [PMID: 37001440 DOI: 10.1016/j.lungcan.2023.107182] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 02/21/2023] [Accepted: 03/21/2023] [Indexed: 03/29/2023]
Abstract
OBJECTIVE This study investigated the association between occupational asbestos exposure (OAE) and survival in patients with histologically confirmed lung cancer (LC). METHODS This monocentric study was conducted in the Comprehensive Cancer Centre Léon Bérard, Lyon, France. A systematic screening has been in place since 2014 for occupational exposure to carcinogens using a self-assessment questionnaire sent to all patients newly diagnosed with histologically confirmed LC identified through the multidisciplinary LC board from 2014 to 2019. When the physician suspected a work-related exposure from the questionnaire including job history, an occupational cancer consultation was carried out to detail carcinogen exposures and assess if the LC was work-related. Demographics, clinical characteristics and survival data were extracted from medical records. The association between asbestos exposure and overall survival (hazard ratio and 95% confidence intervals) was estimated by Cox proportional hazards regression. RESULTS Overall, 702 patients were eligible to the present study, including 180 patients with OAE. In the crude analysis, LCs assessed as moderately or highly attributable to OAE were associated with decreased overall survival (HR = 1.32, 95 %CI 1.04-1.67) compared to LC without OAE or with a low degree of imputability to OAE (median follow-up 28.8 months). After adjustment for confounding (age at diagnosis, smoking status, stage, brain metastasis at diagnosis, and histology), the association of OAE with overall survival was no longer statistically significant (HR = 1.21, 95 %CI 0.94-1.56). CONCLUSION Overall survival in occupationally asbestos exposed LC patients may be decreased in comparison with non-exposed LC patients, warranting further investigations in larger studies.
Collapse
|
4
|
Cabréra L, Auguste A, Michineau L, Joachim C, Deloumeaux J, Luce D. Lung Cancer in the French West Indies: Role of Sugarcane Work and Other Occupational Exposures. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:13444. [PMID: 36294021 PMCID: PMC9603435 DOI: 10.3390/ijerph192013444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Revised: 10/11/2022] [Accepted: 10/14/2022] [Indexed: 06/16/2023]
Abstract
OBJECTIVE Our aim was to study the role of occupational exposures in lung cancer risk in the French West Indies, with special attention to some specific activities, such as sugarcane work, that can only be studied in a limited number of populations. METHODS We used data from a population-based case-control study that included 147 incident lung cancer cases and 405 controls. Smoking histories and detailed occupational histories with descriptions of tasks and substances were collected by questionnaire during face-to-face interviews. Odds ratios (OR) adjusted for sex, age, region, smoking status, and cigarette pack-years and 95% confidence intervals (95% CI) were estimated by unconditional logistic regression. RESULTS Significantly increased risks of lung cancer were found in sugarcane farm workers (OR = 2.7; 95% CI 1.1-6.6) and more generally in the sugarcane-growing sector (OR = 2.5; 95% CI 1.0-6.3) and to a lesser extent in rum production. Elevated risks of lung cancer were also observed among other agricultural workers, painters, warehouse porters, labourers, and maintenance and motor vehicle repair workers. Exposure to herbicides in sugarcane cultivation was associated with an increased risk of lung cancer (OR = 2.6; 95% CI 0.9-7.6). CONCLUSION These results show that occupational exposures contributed to lung cancer risk in the French West Indies, and highlighted the role of exposures related to sugarcane work.
Collapse
Affiliation(s)
- Léïla Cabréra
- Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, EHESP, Inserm, Univ Rennes, F-97100 Pointe-à-Pitre, Guadeloupe, France
| | - Aviane Auguste
- Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, EHESP, Inserm, Univ Rennes, F-97100 Pointe-à-Pitre, Guadeloupe, France
| | - Léah Michineau
- Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, EHESP, Inserm, Univ Rennes, F-97100 Pointe-à-Pitre, Guadeloupe, France
| | - Clarisse Joachim
- Martinique Cancer Registry, UF 1441 Registre des cancers, Pôle de Cancérologie Hématologie Urologie Pathologie, University Hospital of Martinique, F-97200 Fort-de-France, Martinique, France
| | - Jacqueline Deloumeaux
- General Cancer Registry of Guadeloupe, University Hospital of Guadeloupe, F-97100 Pointe-à-Pitre, Guadeloupe, France
| | - Danièle Luce
- Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, EHESP, Inserm, Univ Rennes, F-97100 Pointe-à-Pitre, Guadeloupe, France
| |
Collapse
|
5
|
Les cancers induits par les expositions professionnelles : les progrès. Bull Cancer 2022; 109:1029-1039. [DOI: 10.1016/j.bulcan.2022.05.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Revised: 03/29/2022] [Accepted: 05/09/2022] [Indexed: 11/17/2022]
|
6
|
Pestak CR, Boyce TW, Myers OB, Hopkins' LO, Wiggins CL, Wissore BR, Sood A, Cook LS. A Population-Based Feasibility Study of Occupation and Thoracic Malignancies in New Mexico. SOUTHWEST JOURNAL OF PULMONARY AND CRITICAL CARE 2021; 22:23-25. [PMID: 33614198 DOI: 10.13175/swjpcc067-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Background Occupational exposures in mining and oil/gas extraction are known risk factors for thoracic malignancies (TMs). Given the relatively high proportion of these industries in New Mexico (NM), we conducted a feasibility study of adult lifetime occupational history among TM cases. We hypothesized a higher proportion of occupational TM in NM relative to the estimated national average of 10-14%. Methods We identified incident TM cases through the population-based New Mexico Tumor Registry (NMTR), from 2017-2018. Cases completed a telephone interview. An adjudication panel reviewed case histories and classified cancers as probable, possible, or non-occupational related, taking into account the presence, duration, and latency of exposures. We characterized recruitment and describe job titles and exposures among those with occupational TMs. We also compared the distributions of industry between those with and without occupational TM. Results The NMTR identified 400 eligible TM cases, 290 of which were available to be recruited (n=285 lung/bronchial cancer; n=5 mesotheliomas). Of the latter, 60% refused and 18% were deceased, 9% had invalid addresses, 11% were unable to be reached by telephone, and 3% were too ill to participate. The 43 cases who completed an interview held 236 jobs. A total of 33% of cases were classified as probable occupational TM and 5% as possible occupational TM. Conclusions High rates of early mortality and refusals were significant barriers to study participation. Nonetheless, the proportion of probable occupational TMs greatly exceeded the estimated national average, highlighting the need for further study of occupational TM in the state.
Collapse
Affiliation(s)
- Claire R Pestak
- UNM Comprehensive Cancer Center, University of New Mexico, MSC 07-4025, 1 UNM, Albuquerque, NM, 87131, USA.,New Mexico Tumor Registry, University of New Mexico, MSC 11 6020, 1 UNM, Albuquerque, NM, 87131, USA
| | - Tawny W Boyce
- UNM Comprehensive Cancer Center, University of New Mexico, MSC 07-4025, 1 UNM, Albuquerque, NM, 87131, USA
| | - Orrin B Myers
- Department of Family and Community Medicine, University of New Mexico School of Medicine, MSC 09-5040, 1 UNM, Albuquerque, NM, 87131, USA
| | - L Olivia Hopkins'
- Department of Internal Medicine, University of New Mexico School of Medicine, MSC 10 5550, 1 UNM, Albuquerque, NM, 87131, USA
| | - Charles L Wiggins
- UNM Comprehensive Cancer Center, University of New Mexico, MSC 07-4025, 1 UNM, Albuquerque, NM, 87131, USA.,New Mexico Tumor Registry, University of New Mexico, MSC 11 6020, 1 UNM, Albuquerque, NM, 87131, USA.,Department of Internal Medicine, University of New Mexico School of Medicine, MSC 10 5550, 1 UNM, Albuquerque, NM, 87131, USA
| | - Bruce R Wissore
- Department of Internal Medicine, University of New Mexico School of Medicine, MSC 10 5550, 1 UNM, Albuquerque, NM, 87131, USA.,Southwestern Illinois College, Belleville, IL, 62221, USA
| | - Akshay Sood
- Department of Internal Medicine, University of New Mexico School of Medicine, MSC 10 5550, 1 UNM, Albuquerque, NM, 87131, USA.,Miners Colfax Medical Center, Raton, NM, 87740, USA
| | - Linda S Cook
- UNM Comprehensive Cancer Center, University of New Mexico, MSC 07-4025, 1 UNM, Albuquerque, NM, 87131, USA.,Department of Internal Medicine, University of New Mexico School of Medicine, MSC 10 5550, 1 UNM, Albuquerque, NM, 87131, USA
| |
Collapse
|
7
|
Cabréra L, Auguste A, Michineau L, Deloumeaux J, Joachim C, Luce D. [Occupational and environmental risk factors for lung cancer in the French West Indies]. Med Sci (Paris) 2020; 36 Hors série n° 1:11-15. [PMID: 33052087 DOI: 10.1051/medsci/2020175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Léïla Cabréra
- Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-97100, Pointe-à-Pitre, France
| | - Aviane Auguste
- Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-97100, Pointe-à-Pitre, France
| | - Léah Michineau
- Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-97100, Pointe-à-Pitre, France
| | - Jacqueline Deloumeaux
- Registre général des cancers de Guadeloupe, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France
| | - Clarisse Joachim
- CHU Martinique, UF1441 Registre des cancers de la Martinique, Pôle de Cancérologie Hématologie Urologie Pathologie, Fort-de-France, France
| | - Danièle Luce
- Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-97100, Pointe-à-Pitre, France
| |
Collapse
|
8
|
Marant Micallef C, Shield KD, Vignat J, Baldi I, Charbotel B, Fervers B, Gilg Soit Ilg A, Guénel P, Olsson A, Rushton L, Hutchings SJ, Cléro E, Laurier D, Scanff P, Bray F, Straif K, Soerjomataram I. Cancers in France in 2015 attributable to occupational exposures. Int J Hyg Environ Health 2019; 222:22-29. [PMID: 30174219 DOI: 10.1016/j.ijheh.2018.07.015] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2018] [Revised: 07/19/2018] [Accepted: 07/27/2018] [Indexed: 12/11/2022]
Abstract
BACKGROUND Recent and comprehensive estimates for the number of new cancer cases in France attributable to occupational exposures are lacking. OBJECTIVES To estimate the number of new cancer cases attributable to occupational exposures, using a newly developed methodology and the most recent data, for a comprehensive set of occupational carcinogens in France in 2015. METHODS Surveys among employees, the national labor force data, a cohort of agricultural workers, national monitoring of workers exposed to ionizing radiation and job-exposure matrix in France were used. The number and proportion of new cancer cases attributable to established occupational carcinogens (Group 1) was estimated using estimation of lifetime exposure and risk estimates from cohort studies. Cancer data were obtained from the French Cancer Registries Network. RESULTS In France in 2015, an estimated 7905 new cancer cases, 7336 among men and 569 among women, were attributable to occupational exposures, representing 2.3% of all new cancer cases (3.9% and 0.4% among men and women respectively). Among men and women, lung cancer was impacted the most, followed by mesothelioma and bladder cancer in men, and by mesothelioma and ovary in women. These cancers contributed to 89% of the total cancers attributable to occupational carcinogens in men, and to 80% in women. The main contributing occupational agent was asbestos among men (45%) and women (60%). CONCLUSIONS Currently, occupational exposures contribute to a substantial burden of cancer in France. Enhanced monitoring and implementation of protective labor policies could potentially prevent a large proportion of these cancers.
Collapse
Affiliation(s)
- Claire Marant Micallef
- Section of Cancer Surveillance, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
| | - Kevin D Shield
- Section of Cancer Surveillance, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
| | - Jérôme Vignat
- Section of Cancer Surveillance, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
| | - Isabelle Baldi
- Equipe Santé Environnement, Centre de recherche INSERM U 897, Université de Bordeaux, Bât. ISPED - Case 11, 146, rue Léo-Saignat, Bordeaux, France.
| | - Barbara Charbotel
- Université Lyon 1, UMRESTTE, UMR_T9405, Service des maladies professionnelles, Hospices Civils de Lyon, 8, avenue Rockefeller, 69008, Lyon, France.
| | - Béatrice Fervers
- Centre Léon Bérard, Université de Lyon, Département cancer environnement, 28 rue Laennec, 69008, Lyon, France.
| | - Anabelle Gilg Soit Ilg
- Santé publique France, Direction Santé Travail, 12, rue du Val d'Osne, 94 415, Saint-Maurice cedex, France.
| | - Pascal Guénel
- Centre de recherche en Epidémiologie et Santé des Populations (CESP), Cancer and Environment team, Université Paris-Sud, Université Paris-Saclay, 16, avenue Paul Vaillant Couturier, 94800, Villejuif, France.
| | - Ann Olsson
- Section of Environment and Radiation, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
| | - Lesley Rushton
- Department of Epidemiology and Biostatistics, Imperial College London, Level 2, Faculty Building, South Kensington Campus, London, SW7 2AZ, United Kingdom.
| | - Sally J Hutchings
- Manchester University, Population Health, Health Services Research & Primary Care, School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
| | - Enora Cléro
- Direction of Health and Environment, Institute for Radiological Protection and Nuclear Safety, 31, avenue de la Division Leclerc 92260, Fontenay-aux-Roses, 92260, France.
| | - Dominique Laurier
- Direction of Health and Environment, Institute for Radiological Protection and Nuclear Safety, 31, avenue de la Division Leclerc 92260, Fontenay-aux-Roses, 92260, France.
| | - Pascale Scanff
- Direction of Health and Environment, Institute for Radiological Protection and Nuclear Safety, 31, avenue de la Division Leclerc 92260, Fontenay-aux-Roses, 92260, France.
| | - Freddie Bray
- Section of Cancer Surveillance, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
| | - Kurt Straif
- Section of Evidence Synthesis and Classification, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
| | - Isabelle Soerjomataram
- Section of Cancer Surveillance, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon, CEDEX 08, France.
| |
Collapse
|
9
|
Maille A, Paleiron N, Grassin F, André M, Dewitte JD, Pougnet R. [Asbestos in the National Navy: Employment-exposure matrix]. REVUE DE PNEUMOLOGIE CLINIQUE 2018; 74:436-443. [PMID: 30269937 DOI: 10.1016/j.pneumo.2018.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Revised: 08/20/2018] [Accepted: 08/25/2018] [Indexed: 06/08/2023]
Abstract
INTRODUCTION The odd risk ratio for an asbestos-related disease is 6.9 for National Defense personnel and 94% of the victims who are compensated belong to the French Navy. While employment-exposure matrices exist for the civilian environment, none are available to the military. Our work consists of the creation of the first employment-exposure matrix in the French Navy, in order to optimize post-occupational medical surveillance. METHOD We conducted a bibliographic search for asbestos in naval repair, naval embarking and foreign navies. From databases such as Medline, Pubmed, we used the following keywords "Navy", "Asbestos", "Shypyard" and "Military" and we have extended ourselves to the registers of existing theses on the subject. RESULTS Epidemiological and bibliographic data confirm the increased risk in the French Navy. Three variables are important in the proposal of this employment-exposure matrix: employment, year of arming the ship and duration of embarkation. There is a major risk for personnel whose work is in direct contact with asbestos, in particular machine personnel, irrespective of their duration of exposure. For embarked personnel who do not have direct contact with asbestos in their jobs, the increase in risk depends essentially on the ship's year of arming and the presence of asbestos, whether or not on board, as well as the duration of exposure of seafarers. CONCLUSION These results allow us to recommend a classification of the risk in accordance with the recommendations of the French Health Authority and to propose an adequate post-professional follow-up for the personnel of the Navy.
Collapse
Affiliation(s)
- A Maille
- Centre médical du 44(e) Régiment de transmission, 67190 Mutzig, France
| | - N Paleiron
- Service des maladies respiratoires, HIA Clermont-Tonnerre, 29200 Brest, France
| | - F Grassin
- Service des maladies respiratoires, HIA Clermont-Tonnerre, 29200 Brest, France
| | - M André
- Service des maladies respiratoires, HIA Clermont-Tonnerre, 29200 Brest, France
| | - J D Dewitte
- Centre des maladies professionnelles et environnementales, CHRU Morvan, 29200 Brest, France; EA 3149, laboratoire d'études et de recherches en sociologie, LABERS, université de Bretagne Occidentale, 29200 Brest, France
| | - R Pougnet
- Centre des maladies professionnelles et environnementales, CHRU Morvan, 29200 Brest, France; EA 3149, laboratoire d'études et de recherches en sociologie, LABERS, université de Bretagne Occidentale, 29200 Brest, France.
| |
Collapse
|
10
|
Pérol O, Charbotel B, Perrier L, Bonnand S, Belladame E, Avrillon V, Rebattu P, Gomez F, Lauridant G, Pérol M, Fervers B. Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2018; 15:E65. [PMID: 29300325 PMCID: PMC5800164 DOI: 10.3390/ijerph15010065] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/01/2017] [Revised: 12/22/2017] [Accepted: 12/27/2017] [Indexed: 11/18/2022]
Abstract
Occupational lung cancers are under-reported and under-compensated worldwide. We assessed systematic screening for occupational exposure to carcinogens combining a self-administered questionnaire and an occupational consultation to improve the detection of occupational lung cancers and their compensation. Social deprivation and the costs of this investigation were estimated. Patients with lung cancer received a self-administered questionnaire to collect their job history, potential exposure to carcinogens and deprivation. A physician assessed the questionnaire and recommended an occupational consultation if necessary. During the consultation, a physician assessed if the lung cancer was work-related and, if it was, delivered a medical certificate to claim for compensation. Over 18 months, 440 patients received the self-administered questionnaire: 234 returned a completed questionnaire and a consultation was required for 120 patients. Compensation was judged possible for 41 patients. Among the 35 medical certificates delivered, 19 patients received compensation. Nearly half the patients (46%) were assessed as socially deprived and these patients took significantly longer to return the questionnaire compared with those who were not deprived. The mean cost of the process was €62.65 per patient. Our results showed a systematic self-administered questionnaire can be used to identify patients potentially exposed to carcinogens and to improve compensation.
Collapse
Affiliation(s)
- Olivia Pérol
- Département Cancer et Environnement, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
| | - Barbara Charbotel
- Université Lyon 1, UMRESTTE (Unité Mixte IFSTTAR/UCBL), 69373 Lyon CEDEX 03, France.
- Hospices Civils de Lyon, Service des Maladies Professionnelles, Centre Hospitalier Lyon Sud, 69495 Pierre Bénite, France.
| | - Lionel Perrier
- Université Lyon, Centre Léon Bérard, GATE L-SE UMR 5824, F-69008 Lyon, France.
| | - Sandrine Bonnand
- Département Interdisciplinaire de soins de Support du Patient en Oncologie, Service Social, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
| | - Elodie Belladame
- Département Cancer et Environnement, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
| | - Virginie Avrillon
- Département d'Oncologie Médicale, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
| | - Paul Rebattu
- Département d'Oncologie Médicale, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
| | - Frédéric Gomez
- Département d'Information Médicale, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
| | - Géraldine Lauridant
- Département d'Oncologie Médicale, Centre Oscar Lambret, 59000 Lille, France.
| | - Maurice Pérol
- Département d'Oncologie Médicale, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
| | - Beatrice Fervers
- Département Cancer et Environnement, Centre Léon Bérard, 69373 Lyon CEDEX 08, France.
- Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, F-69008 Lyon, France.
| |
Collapse
|